Scientists at UC San Francisco and Gladstone Institutes have identified cancer drugs that promise to reverse the changes that occur in the brain during Alzheimer’s, potentially slowing or even ...

Alzheimer’s disease remains one of medicine’s toughest challenges, affecting millions and costing trillions of dollars annually. If someone you know has Alzheimer’s, you’ve likely experienced ...

A study comparing the gene expression signature of Alzheimer's disease with those elicited by 1,300 approved drugs found a combination of two cancer medications that could treat the most common form ...

In a stunning scientific discovery, researchers have found that a pair of drugs can not only slow down Alzheimer’s disease but actually reverse it and restore memory in mice. And the best part of all?

In an exciting breakthrough, researchers have identified cancer drugs that might reverse the effects of Alzheimer's disease in the brain. By analyzing gene expression in brain cells, they discovered ...

Here’s what you’ll learn when you read this story: Treating Alzheimer’s requires a multi-faceted approach that can target various mechanisms behind this pernicious neurodegenerative disease. In a new ...

GLP-1 receptor agonists, a class of drug used to treat type 2 diabetes, likely trump the widely prescribed metformin for curbing dementia risk in people with the condition, finds the largest study of ...

A redesigned immune-activating cancer drug has produced striking early results in a small clinical trial, shrinking tumors ...

A UCSF and Gladstone Institutes team discovered a pair of cancer drugs that successfully treated a model of severe Alzheimer’s disease. From left: Marina Sirota, PhD; Yaqiao Li, PhD; and Yadong Huang, ...